Chapel Hill, NC, United States of America

Yun Fu Hu

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 69(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Yun Fu Hu: Innovating in Cardiovascular Health

Introduction

Yun Fu Hu, a prominent inventor located in Chapel Hill, NC, has made significant contributions to the field of medical innovations. With a robust portfolio of five patents, his work primarily focuses on biomarkers related to cardiovascular diseases and insulin resistance, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Among his notable patents is "Biomarkers for cardiovascular diseases and methods using the same." This patent details biomarkers that are linked to cardiovascular diseases, specifically atherosclerosis and cardiomyopathy. It outlines various methodologies for utilizing these biomarkers to assess the conditions effectively. Furthermore, it introduces suites of small molecule entities that serve as biomarkers, enhancing the diagnostic capabilities for these cardiovascular disorders.

Another significant patent from Yun Fu Hu is "Biomarkers for insulin resistance and methods using the same." This innovation provides a comprehensive framework for identifying biomarkers associated with insulin resistance. It also elaborates on methods to employ these biomarkers, further expanding the toolkit available for diagnosing and treating this prevalent metabolic condition.

Career Highlights

Yun Fu Hu works with Metabolon, Inc., where he applies his research expertise to address critical health challenges. His contributions to the field can help improve patient outcomes and offer new avenues for treatment, reflecting his dedication to innovation in healthcare.

Collaborations

Throughout his career, Yun Fu Hu has collaborated with fellow researchers and professionals, including Costel Chirila and Danny Alexander. These partnerships have fostered a collaborative spirit that enhances the development of groundbreaking medical solutions.

Conclusion

In summary, Yun Fu Hu is an accomplished inventor whose work in biomarkers for cardiovascular diseases and insulin resistance is paving the way for innovative healthcare solutions. His expertise and collaborations at Metabolon, Inc. reflect not only his dedication to the field but also his commitment to improving patient health through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…